Alice Vergauwen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alice Vergauwen has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Sandra Nuyts
Department of Radiation Oncology, Leuven Cancer Institute University Hospitals Leuven Leuven Belgium
5 shared publications - Hanne Massonet
Department of Translational Neurosciences University of Antwerp Antwerp Belgium
4 shared publications Leen Van Den Steen
Department of Translational Neurosciences University of Antwerp Antwerp Belgium
4 shared publications- Fréderic Duprez
Department of Human Structure and Repair Ghent University Ghent Belgium
3 shared publications - Gwen Van Nuffelen
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
3 shared publications - Gwen Van Nuffelen
Department of Translational Neurosciences University of Antwerp Antwerp Belgium
3 shared publications
Latest Publications
- 20 October 2026
- Published by Wiley in Head & Neck
Cost Effectiveness Analysis of the Presto‐Trial: A Three‐Armed RCT Evaluating Prophylactic Swallowing Exercises in Head and Neck Cancer Patients During (Chemo)radio Treatment
Background: Research on oropharyngeal head and neck cancer (HNC) patients indicates that prophylactic swallowing exercises (PSE) during (C)RT can positively affect muscle strength, swallowing function and quality of life (QOL). Primary analyses of the PRESTO‐trial showed higher adherence rates for PSE when exercising daily with a speech‐language pathologist (SLP), compared to self‐guided exercises with either an exercise diary or a digital application. Additionally, higher adherence rates were related to greater improvements in swallowing function and QOL. However, given limited healthcare resources, cost‐effectiveness analyses are essential to inform the implementation of such rehabilitation strategies in dysphagia care. This secondary analysis of the PRESTO‐data compares the costs and health effects of the three different service models: app‐based, therapist‐led (daily face‐to‐face, 20 sessions during (C)RT), and paper‐led therapy. Methods: One hundred fifty patients receiving (chemo)radiotherapy (C)RT for oropharyngeal HNC were randomly assigned to one of the three exercise groups. All performing the same PSE protocol. The treatment protocol required daily training during the first 4 weeks of the (C)RT treatment program. Patients in the therapy group thereby received a total of 20 face‐to‐face therapy sessions. Health outcomes were expressed as utilities based on the EQ5D5L instrument measured at baseline, post (C)RT and 3 months post (C)RT. Costs were estimated from a health service perspective, including staff time, therapy resources and consumables. Incremental cost‐effectiveness ratios (ICERs) were calculated as ΔCosts/ ΔQALYs. Results: No significant between‐group differences were found for utilities. Only significant time effects were observed, with a significant decrease in utilities from baseline to post (C)RT and a significant increase from post (C)RT to 3 months post (C)RT. The therapist‐led intervention was associated with the highest costs. The app‐group intervention was dominated by the paper group in terms of cost‐effectiveness as the utilities were comparable but at a higher cost in the app‐group. Consequently, the ICER was computed between the paper‐group and therapist‐group and resulted in € 124 061,54/QALY. Conclusions: Despite the overall positive HR‐QOL effects post 3 months, the daily therapist‐led delivery of PSE therapy was not cost‐effective relative to paper‐based self‐management. Under current resource constraints, low‐cost delivery models represent the most economically efficient option. Future research should explore whether hybrid or targeted therapist involvement yields better value by preserving clinical benefit while reducing cost.
- 20 October 2026
- Published by Wiley in Head & Neck
Cost Effectiveness Analysis of the Presto‐Trial: A Three‐Armed RCT Evaluating Prophylactic Swallowing Exercises in Head and Neck Cancer Patients During (Chemo)radio Treatment
Background: Research on oropharyngeal head and neck cancer (HNC) patients indicates that prophylactic swallowing exercises (PSE) during (C)RT can positively affect muscle strength, swallowing function and quality of life (QOL). Primary analyses of the PRESTO‐trial showed higher adherence rates for PSE when exercising daily with a speech‐language pathologist (SLP), compared to self‐guided exercises with either an exercise diary or a digital application. Additionally, higher adherence rates were related to greater improvements in swallowing function and QOL. However, given limited healthcare resources, cost‐effectiveness analyses are essential to inform the implementation of such rehabilitation strategies in dysphagia care. This secondary analysis of the PRESTO‐data compares the costs and health effects of the three different service models: app‐based, therapist‐led (daily face‐to‐face, 20 sessions during (C)RT), and paper‐led therapy. Methods: One hundred fifty patients receiving (chemo)radiotherapy (C)RT for oropharyngeal HNC were randomly assigned to one of the three exercise groups. All performing the same PSE protocol. The treatment protocol required daily training during the first 4 weeks of the (C)RT treatment program. Patients in the therapy group thereby received a total of 20 face‐to‐face therapy sessions. Health outcomes were expressed as utilities based on the EQ5D5L instrument measured at baseline, post (C)RT and 3 months post (C)RT. Costs were estimated from a health service perspective, including staff time, therapy resources and consumables. Incremental cost‐effectiveness ratios (ICERs) were calculated as ΔCosts/ ΔQALYs. Results: No significant between‐group differences were found for utilities. Only significant time effects were observed, with a significant decrease in utilities from baseline to post (C)RT and a significant increase from post (C)RT to 3 months post (C)RT. The therapist‐led intervention was associated with the highest costs. The app‐group intervention was dominated by the paper group in terms of cost‐effectiveness as the utilities were comparable but at a higher cost in the app‐group. Consequently, the ICER was computed between the paper‐group and therapist‐group and resulted in € 124 061,54/QALY. Conclusions: Despite the overall positive HR‐QOL effects post 3 months, the daily therapist‐led delivery of PSE therapy was not cost‐effective relative to paper‐based self‐management. Under current resource constraints, low‐cost delivery models represent the most economically efficient option. Future research should explore whether hybrid or targeted therapist involvement yields better value by preserving clinical benefit while reducing cost.
- 5 March 2026
- Published by Wiley in Head & Neck
- Vol. 48 (8) , 2030-2047
Dysphagia Rehabilitation Outcomes in Head and Neck Cancer Patients With Radiation Associated Dysphagia: Does Time Since (Chemo)radiation Matter?
Background: Since radiation‐associated dysphagia may evolve in the months to years following (chemo)radiotherapy (C/RT), it is important to determine whether swallowing‐related outcomes vary according to the time elapsed since cancer treatment. This may help to determine the time window in which a patient might benefit most from dysphagia rehabilitation. Methods: Fifty‐four patients were stratified into three groups based on the time since completion of the C/RT: < 1 year; 1–5 years; > 5 years post‐C/RT. Differences in swallowing‐related outcomes were compared at baseline and after 8 weeks of swallowing rehabilitation. Results: Swallowing‐related outcomes were significantly worse at baseline in patients who were more than 5 years post‐C/RT compared to those less than 5 years post‐C/RT. Nevertheless, these patients still show significant and comparable improvements in swallowing‐related outcomes after 8 weeks of swallowing rehabilitation. Conclusions: Although patients more than 5 years post‐C/RT exhibited worse swallowing‐related outcomes compared to those less than 5 years post‐C/RT, these patients remain viable candidates for swallowing rehabilitation. Trial Registration: ClinicalTrials.gov identifier: ISRCTN57028065.
- 5 March 2026
- Published by Wiley in Head & Neck
- Vol. 48 (8) , 2030-2047
Dysphagia Rehabilitation Outcomes in Head and Neck Cancer Patients With Radiation Associated Dysphagia: Does Time Since (Chemo)radiation Matter?
Background: Since radiation‐associated dysphagia may evolve in the months to years following (chemo)radiotherapy (C/RT), it is important to determine whether swallowing‐related outcomes vary according to the time elapsed since cancer treatment. This may help to determine the time window in which a patient might benefit most from dysphagia rehabilitation. Methods: Fifty‐four patients were stratified into three groups based on the time since completion of the C/RT: < 1 year; 1–5 years; > 5 years post‐C/RT. Differences in swallowing‐related outcomes were compared at baseline and after 8 weeks of swallowing rehabilitation. Results: Swallowing‐related outcomes were significantly worse at baseline in patients who were more than 5 years post‐C/RT compared to those less than 5 years post‐C/RT. Nevertheless, these patients still show significant and comparable improvements in swallowing‐related outcomes after 8 weeks of swallowing rehabilitation. Conclusions: Although patients more than 5 years post‐C/RT exhibited worse swallowing‐related outcomes compared to those less than 5 years post‐C/RT, these patients remain viable candidates for swallowing rehabilitation. Trial Registration: ClinicalTrials.gov identifier: ISRCTN57028065.
- Open Access
- 9 February 2026
- Published by Springer Nature in Dysphagia
- Vol. 41 (3) , 682-691
Adherence To Prophylactic Swallowing Exercises in Head and Neck Cancer Patients (PRESTO-TRIAL) - the ROLE of Personality Characteristics
Prophylactic swallowing exercises (PSE) can mitigate (the consequences of) radiation associated dysphagia (RAD) in head and neck cancer (HNC) patients, provided patients adhere to a high-intensity program. However, patient adherence, a multifactorial concept influenced by several confounders, has been found to vary considerably between studies and individuals. PSE-related adherence confounders such as gender, smoking at baseline, baseline depression and high baseline fatigue levels have already been postulated. The influence of personality on adherence to PSE has not yet been investigated. Therefore, the aim of this secondary analysis of the Presto-trial is to examine the influence of personality traits on overall adherence rates to a PSE-program. One hundred fifty patients with a stage III or IVA-B (TNM7) newly diagnosed squamous cell carcinoma of the oropharynx -treated with (chemo)radiotherapy (C)RT - were included in the PRESTO-trial. One hundred sixteen out of the 150 participants completed the NEO Five Factor Inventory (NEO-FFI) personality questionnaire prior to starting RT. The NEO-FFI is a validated 60 item self-report questionnaire with 12 items per personality trait (neuroticism, extraversion, altruïsm, conscientiousness and openness). Statistical analysis was performed using simple and multiple regression models for the 5 personality traits. This study shows that the personality trait openness significantly influences overall adherence rates to PSE in HNC (p = 0.047). Higher scores on the personality trait openness increase overall adherence rates (β = 0.058, SE = 0.0290). Although, this singular statistical result has a very small effect size (OR 1.06), meaning that it is not likely a meaningful difference to consider any practice change. The personality traits extraversion, neuroticism, conscientiousness and altruism are not significantly related to overall adherence during PSE. This study is the first to explore the relationship between personality traits and adherence to PSE in HNC. While openness showed a statistically significant association with overall adherence, the effect size was very small and is unlikely to be of clinical relevance. No other personality traits demonstrated a significant relationship with adherence.
- 9 February 2026
- Published by Springer Nature in Dysphagia
- Vol. 41 (3) , 682-691
Open AccessAdherence To Prophylactic Swallowing Exercises in Head and Neck Cancer Patients (PRESTO-TRIAL) - the ROLE of Personality Characteristics
Prophylactic swallowing exercises (PSE) can mitigate (the consequences of) radiation associated dysphagia (RAD) in head and neck cancer (HNC) patients, provided patients adhere to a high-intensity program. However, patient adherence, a multifactorial concept influenced by several confounders, has been found to vary considerably between studies and individuals. PSE-related adherence confounders such as gender, smoking at baseline, baseline depression and high baseline fatigue levels have already been postulated. The influence of personality on adherence to PSE has not yet been investigated. Therefore, the aim of this secondary analysis of the Presto-trial is to examine the influence of personality traits on overall adherence rates to a PSE-program. One hundred fifty patients with a stage III or IVA-B (TNM7) newly diagnosed squamous cell carcinoma of the oropharynx -treated with (chemo)radiotherapy (C)RT - were included in the PRESTO-trial. One hundred sixteen out of the 150 participants completed the NEO Five Factor Inventory (NEO-FFI) personality questionnaire prior to starting RT. The NEO-FFI is a validated 60 item self-report questionnaire with 12 items per personality trait (neuroticism, extraversion, altruïsm, conscientiousness and openness). Statistical analysis was performed using simple and multiple regression models for the 5 personality traits. This study shows that the personality trait openness significantly influences overall adherence rates to PSE in HNC (p = 0.047). Higher scores on the personality trait openness increase overall adherence rates (β = 0.058, SE = 0.0290). Although, this singular statistical result has a very small effect size (OR 1.06), meaning that it is not likely a meaningful difference to consider any practice change. The personality traits extraversion, neuroticism, conscientiousness and altruism are not significantly related to overall adherence during PSE. This study is the first to explore the relationship between personality traits and adherence to PSE in HNC. While openness showed a statistically significant association with overall adherence, the effect size was very small and is unlikely to be of clinical relevance. No other personality traits demonstrated a significant relationship with adherence.
- 20 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (5) , 1340-1350
Feasibility and Adherence to Home‐Based Intensive Treatment Programs for Chronic Radiation‐Associated Dysphagia in Head and Neck Cancer Survivors—The HIT‐CRAD Trial
Background: The HIT‐CRAD trial (ISRCTN57028065) is the first to combine home‐based non‐invasive brain stimulation with high‐volume strength and skill training over 8 weeks in patients with chronic radiation‐associated dysphagia (CRAD) following primary (chemo)radiotherapy for head and neck cancer. Methods: Fifty‐four patients were randomized into three groups. Group 1 performed 8 weeks of strength training. Groups 2 and 3 combined 4 weeks of strength training with 4 weeks of skill training. Group 3 received high‐definition transcranial direct current stimulation (HD‐tDCS) during training. Group 2 received sham HD‐tDCS. Results: Overall adherence and exercise adherence remained above 75% across all groups. Home‐based HD‐tDCS proved safe and feasible, with mild to moderate side effects (tingling, itching, or burning). Median exercise performance levels for strength training exercises ranged from 94% to 100%. Conclusions: This study confirms the feasibility of high‐volume strength and skill training with HD‐tDCS in patients with C‐RAD. Proactive adherence‐supporting factors facilitate high adherence in this population. Both real and sham HD‐tDCS proved safe, feasible, and well tolerated. Trial Registration: International Standard Randomized Controlled Trials Number (ISRCTN) registry ID ISRCTN57028065
- 20 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (5) , 1340-1350
Feasibility and Adherence to Home‐Based Intensive Treatment Programs for Chronic Radiation‐Associated Dysphagia in Head and Neck Cancer Survivors—The HIT‐CRAD Trial
Background: The HIT‐CRAD trial (ISRCTN57028065) is the first to combine home‐based non‐invasive brain stimulation with high‐volume strength and skill training over 8 weeks in patients with chronic radiation‐associated dysphagia (CRAD) following primary (chemo)radiotherapy for head and neck cancer. Methods: Fifty‐four patients were randomized into three groups. Group 1 performed 8 weeks of strength training. Groups 2 and 3 combined 4 weeks of strength training with 4 weeks of skill training. Group 3 received high‐definition transcranial direct current stimulation (HD‐tDCS) during training. Group 2 received sham HD‐tDCS. Results: Overall adherence and exercise adherence remained above 75% across all groups. Home‐based HD‐tDCS proved safe and feasible, with mild to moderate side effects (tingling, itching, or burning). Median exercise performance levels for strength training exercises ranged from 94% to 100%. Conclusions: This study confirms the feasibility of high‐volume strength and skill training with HD‐tDCS in patients with C‐RAD. Proactive adherence‐supporting factors facilitate high adherence in this population. Both real and sham HD‐tDCS proved safe, feasible, and well tolerated. Trial Registration: International Standard Randomized Controlled Trials Number (ISRCTN) registry ID ISRCTN57028065
- Open Access
- 5 December 2025
- Published by Springer Nature in Current Otorhinolaryngology Reports
- Vol. 13 (1) , 20
Pre- and Rehabilitation of Swallowing in Head and Neck Cancer Patients
- 5 December 2025
- Published by Springer Nature in Current Otorhinolaryngology Reports
- Vol. 13 (1) , 20
Open AccessPre- and Rehabilitation of Swallowing in Head and Neck Cancer Patients
- Open Access
- 24 January 2025
- Published by Wiley in Head & Neck
- Vol. 47 (6) , 1717-1725
Exploratory Research: Patient‐Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer
Background: Radiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation‐associated dysphagia (RAD). These factors threaten patients' oral intake (OI) during this RT. Reduced OI can cause weight loss, dehydration, malnutrition, and various comorbidities. On top, reduced OI significantly affects quality of life and may contribute to RAD through the disuse of swallowing muscles. With the aim of maximizing the retention of a patient's OI, it is important to gain an insight into the factors that have the greatest impact. Therefore, this study aims to identify the impact of contributing factors on decreased OI during RT. Methods: During their treatment, 55 HNC patients completed an OI questionnaire at 5 different time points: during weeks 1, 2, 3, and 4 and at the end of RT (week 7). First, patients rated the OI compared to pre‐RT on a 100 mm visual analogue scale (VAS). Subsequently, patients reported on separate VAS the degree to which pain, fatigue, loss of taste, loss of smell, loss of interest in food, nausea, and loss of hunger contributed to the decrease in OI (0: no contribution; 100: complete contribution). SPSS version 27 was used to analyze the results. Results: OI decreased over time during RT, with the lowest OI at the end of RT. During the first 4 weeks of RT, the impact of all factors with pain, loss of taste, loss of interest in food, and loss of hunger pointed out as strongest contributing factors to a decreased OI. The most important patient‐reported impacting factor on OI was loss of taste. At the end of RT, the importance of pain and nausea still increases, while the contribution of the other factors drops slightly. Conclusion: This cohort study shows that several factors contribute to a decreased OI in HNC patients during RT. This study is the first prospective analysis to identify self‐reported factors contributing to reduced OI. Results demonstrate that taste has the greatest impact on OI followed by loss of interest in food, loss of hunger, and pain.
- 24 January 2025
- Published by Wiley in Head & Neck
- Vol. 47 (6) , 1717-1725
Open AccessExploratory Research: Patient‐Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer
Background: Radiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation‐associated dysphagia (RAD). These factors threaten patients' oral intake (OI) during this RT. Reduced OI can cause weight loss, dehydration, malnutrition, and various comorbidities. On top, reduced OI significantly affects quality of life and may contribute to RAD through the disuse of swallowing muscles. With the aim of maximizing the retention of a patient's OI, it is important to gain an insight into the factors that have the greatest impact. Therefore, this study aims to identify the impact of contributing factors on decreased OI during RT. Methods: During their treatment, 55 HNC patients completed an OI questionnaire at 5 different time points: during weeks 1, 2, 3, and 4 and at the end of RT (week 7). First, patients rated the OI compared to pre‐RT on a 100 mm visual analogue scale (VAS). Subsequently, patients reported on separate VAS the degree to which pain, fatigue, loss of taste, loss of smell, loss of interest in food, nausea, and loss of hunger contributed to the decrease in OI (0: no contribution; 100: complete contribution). SPSS version 27 was used to analyze the results. Results: OI decreased over time during RT, with the lowest OI at the end of RT. During the first 4 weeks of RT, the impact of all factors with pain, loss of taste, loss of interest in food, and loss of hunger pointed out as strongest contributing factors to a decreased OI. The most important patient‐reported impacting factor on OI was loss of taste. At the end of RT, the importance of pain and nausea still increases, while the contribution of the other factors drops slightly. Conclusion: This cohort study shows that several factors contribute to a decreased OI in HNC patients during RT. This study is the first prospective analysis to identify self‐reported factors contributing to reduced OI. Results demonstrate that taste has the greatest impact on OI followed by loss of interest in food, loss of hunger, and pain.
- Open Access
- 21 October 2024
- Published by Springer Nature in Dysphagia
- Vol. 40 (4) , 737-746
Head and Neck Cancer Survivors’ Assessment of Mealtimes: Translation and Validation
Dysphagia is a prevalent complication before, during and after treatment for head and neck cancer (HNC). Besides the medical and societal consequences, dysphagia has a negative impact on functioning, activity, participation and quality of life. These aspects are all affected by the environmental factors (EF). However, patient-reported outcome measures (PROMS) such as the Head-and-Neck Cancer Survivors’ Assessment of Mealtimes (HNSAM), which thoroughly assess participation and EF in addition to function and activity, are rare. Therefore, this study aimed to translate and validate the HNSAM into Dutch (D-HNSAM). The HNSAM was translated according to the standardized procedure of translation & back-translation and according to the international cross-cultural adaptation process. A pilot study was then conducted with 10 HNC patients to assess the linguistic features and comprehensibility of the test items. Finally, the D-HNSAM was completed by 50 participants who were at least 6 months post-treatment for HNC. The Performance Status Scale for Head and Neck cancer patients (PSS-HN)- subscales normalcy of diet and eating in public, the Dysphagia Handicap Index (DHI), the Functional Oral Intake scale (FOIS) and the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P) were used to examine the psychometric properties of the D-HNSAM. High correlations with related assessment tools and low correlations with unrelated assessment tools were expected. Internal consistency was found to be weak to good. Test–retest reliability, convergent validity and divergent validity were demonstrated except for the EF subscale. The D-HNSAM can detect differences in impact of dysphagia on daily functioning and quality of life. The D-HNSAM is a reliable and clinically valuable PROM for assessing the impact of dysphagia on daily functioning and quality of life in patients with HNC. The unique aspect of this PROM, the subscale EF, has unfortunately weak psychometric properties and requires further refinement.
- 21 October 2024
- Published by Springer Nature in Dysphagia
- Vol. 40 (4) , 737-746
Open AccessHead and Neck Cancer Survivors’ Assessment of Mealtimes: Translation and Validation
Dysphagia is a prevalent complication before, during and after treatment for head and neck cancer (HNC). Besides the medical and societal consequences, dysphagia has a negative impact on functioning, activity, participation and quality of life. These aspects are all affected by the environmental factors (EF). However, patient-reported outcome measures (PROMS) such as the Head-and-Neck Cancer Survivors’ Assessment of Mealtimes (HNSAM), which thoroughly assess participation and EF in addition to function and activity, are rare. Therefore, this study aimed to translate and validate the HNSAM into Dutch (D-HNSAM). The HNSAM was translated according to the standardized procedure of translation & back-translation and according to the international cross-cultural adaptation process. A pilot study was then conducted with 10 HNC patients to assess the linguistic features and comprehensibility of the test items. Finally, the D-HNSAM was completed by 50 participants who were at least 6 months post-treatment for HNC. The Performance Status Scale for Head and Neck cancer patients (PSS-HN)- subscales normalcy of diet and eating in public, the Dysphagia Handicap Index (DHI), the Functional Oral Intake scale (FOIS) and the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P) were used to examine the psychometric properties of the D-HNSAM. High correlations with related assessment tools and low correlations with unrelated assessment tools were expected. Internal consistency was found to be weak to good. Test–retest reliability, convergent validity and divergent validity were demonstrated except for the EF subscale. The D-HNSAM can detect differences in impact of dysphagia on daily functioning and quality of life. The D-HNSAM is a reliable and clinically valuable PROM for assessing the impact of dysphagia on daily functioning and quality of life in patients with HNC. The unique aspect of this PROM, the subscale EF, has unfortunately weak psychometric properties and requires further refinement.